Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors

$Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors$

Journal article

Peer reviewed

Manik Amin, Feng Gao, Gretel Terrero, Joel Picus, Andrea Wang-Gillam, Rama Suresh, Cynthia Ma, Benjamin Tan, Maria Baggstrom, Michael J Naughton, …

American journal of clinical oncology, Vol.44(9), pp.443-448

2021-09

PMID: 34310349

Metrics

5 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis; 1.25.803 mTOR
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors
Creators: Manik Amin
Feng Gao
Gretel Terrero
Joel Picus
Andrea Wang-Gillam
Rama Suresh
Cynthia Ma
Benjamin Tan
Maria Baggstrom
Michael J Naughton
Lauren Trull
Stephanie Belanger
Paula M Fracasso
Albert Craig Lockhart
Publication Details: American journal of clinical oncology, Vol.44(9), pp.443-448
Academic Unit: Miller School of Medicine
Language: English
Resource Type: Journal article
PMID: 34310349
Record Identifier: 991031660580002976